Vail Health Behavioral Health Innovation Center
A collaborative endeavor between Vail Health and the Raison Lab at the University of Wisconsin-Madison, the Vail Health Behavioral Health Innovation Center (BHIC) will serve as a cutting-edge treatment, education, and research site committed to the study and implementation of novel behavioral health interventions for patients located in Eagle County, CO and beyond. Dr. Charles Raison serves as the Director of the Vail Health BHIC, where he is leading investigations into the therapeutic potential of psilocybin as well as heat and cold treatments for the treatment of depression. The Vail Health BHIC is supported by the philanthropic generosity of Mike and Mary Sue Shannon, dedicated University of Wisconsin-Madison alumni and mental health advocates.
The Vail Health BHIC holds a monthly lecture series, Novel Approaches to Behavioral Health Innovation, that features innovative leaders in behavioral health treatment and research and offers continuing education credit for mental health professionals.
Wisconsin Institute for Sleep and Consciousness
The Raison Lab collaborates closely with staff and faculty of the University of Wisconsin-Madison’s Wisconsin Institute for Sleep and Consciousness to support the design and conduct of our studies. Founded in 2017, the Wisconsin Institute for Sleep and Consciousness (WISC) is an academic sleep center housing a multi-disciplinary clinical sleep program complemented by a world-class research group that addresses multiple aspects of both sleep and consciousness.
UW–Madison Transdisciplinary Center for Research in Psychoactive Substances
The mission of the University of Wisconsin–Madison Transdisciplinary Center for Research in Psychoactive Substances is to support research and educational activities regarding psychedelic drugs and related compounds. The center supports the UW–Madison campus and the Wisconsin community with research infrastructure, such as drug dosing rooms, treatment facilitator training, and education.
The Center partners with the Masters of Science program in Psychoactive Pharmaceutical Investigation within the University of Wisconsin-Madison School of Pharmacy to provide the first accredited degree focusing on the study and therapeutic application of psychedelic compounds and related psychoactive drugs. The program is designed to support the training and development of scientists, researchers, and scholars who are looking to become leaders in this rapidly growing segment of the pharmaceutical industry.